Locus Bioscience
  • Home
  • About Us
  • Platforms
  • Programs
  • Careers
  • Media
Contact
Media

News

51 Articles found
News Press Releases Locus Insights

Posts navigation

1 2 3 … 6 Next
  • May 20, 2022

    J&J backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3

    Learn More
  • May 18, 2022

    RTP’s Locus Biosciences closes $35M Series B, investors include J&J and Tencent

    Learn More
  • March 23, 2022

    Locus’ Pac-Man-like precision medicine could negate antibiotic collateral damage

    Learn More
  • March 4, 2022

    The transformation of precision medicine in infectious disease

    Learn More
  • February 14, 2022

    Locus Biosciences raises $10.5M in equity, more funding coming

    Learn More
  • February 8, 2022

    Scrip Asks…What Does 2022 Hold For Biopharma? Part 2: Deal Making, M&A And Financial Markets

    Learn More
  • January 24, 2022

    Deep Dive: Deep Dive Into Bacteriophage’s Potential

    Learn More
  • January 10, 2022

    Precision Approach To Infectious Disease With Locus Biosciences’ Paul Garofolo

    Learn More
  • April 27, 2021

    2021 ISPE Facility of the Year Award Winners

    Learn More
  • April 25, 2021

    It’s DNA Day! Here Are 4 Ways Gene Editing Is Transforming Medicine

    Learn More

Posts navigation

1 2 3 … 6 Next

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.

Join Our Team

Media Inquires


For all media inquiries, please contact
our public relations agency below

Contact Now
Locus Biosciences

Precision Medicines for Bacterial Infections
and Microbiome Diseases

Home

About Us

Platforms

Programs

Careers

Media

Contact

Location

523 Davis Drive Suite 350
Morrisville NC 27560

Email

info@locus-bio.com

Linkedin

Linkedin

Twitter

Twitter

©Copyright 2022 Locus Biosciences, Inc. All rights reserved.

powered by wildfire